Cullinan Therapeutics, Inc. · NASDAQ:CGEM

BVF PARTNERS L P/IL reported a 9.99% stake in Cullinan Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

BVF PARTNERS L P/IL reported a 9.99% stake in Cullinan Therapeutics, Inc., 6,491,123 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
9.99%
Shares
6,491,123
Intent
Passive
What changed
Stake changed
Filed together
10 holders

The filing in full

HolderStakeShares
BIOTECHNOLOGY VALUE FUND L P5.70%3,711,284
BVF I GP LLC5.70%3,711,284
BIOTECHNOLOGY VALUE FUND II LP3.50%2,269,166
BVF II GP LLC3.50%2,269,166
Biotechnology Value Trading Fund OS LP0.60%400,861
BVF Partners OS Ltd.0.60%400,861
BVF GP HOLDINGS LLC9.20%5,980,450
BVF PARTNERS L P/IL9.99%6,491,123
BVF INC/IL9.99%6,491,123
LAMPERT MARK N9.99%6,491,123

Source

View original at SEC

Related